Combination antithrombotic therapy and bleeding risk: comparing atrial fibrillation and venous thromboembolism

被引：0
|
作者：
Song, Melinda [1 ]
Haymart, Brian [1 ]
Kong, Xiaowen [1 ]
Ali, Mona [2 ]
Kozlowski, Jay [3 ]
Krol, Gregory [4 ]
Kaatz, Scott [4 ]
Froehlich, James [1 ]
Barnes, Geoff [1 ]
机构：
[1] Univ Michigan, Ann Arbor, MI 48109 USA
[2] Beaumont Hosp, Royal Oak, MI USA
[3] Detroit Med Ctr, Detroit, MI USA
[4] Henry Ford Hosp, Detroit, MI 48202 USA
来源：
VASCULAR MEDICINE | 2021年 / 26卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
1320
引用
收藏
页码：NP10 / NP10
页数：1
相关论文
共 50 条
  • [1] Bleeding Risk Scores in Atrial Fibrillation and Venous Thromboembolism
    Zulkifly, Hanis
    Lip, Gregory Y. H.
    Lane, Deirdre A.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2017, 120 (07): : 1139 - 1145
  • [2] Atrial fibrillation, thromboembolism and antithrombotic therapy
    Li-Saw-Hee, FL
    Lip, GYH
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 1999, 53 (02) : 110 - 117
  • [3] Risk of bleeding with tong-term antithrombotic therapy in atrial fibrillation
    Schulman, S
    Beyth, RJ
    [J]. EUROPEAN HEART JOURNAL SUPPLEMENTS, 2005, 7 (0C) : C34 - C40
  • [4] Antithrombotic therapy: Is combination antithrombotic therapy safe for patients with atrial fibrillation?
    Myrvang H.
    [J]. Nature Reviews Cardiology, 2010, 7 (12) : 665 - 665
  • [5] Antithrombotic treatment switching in elderly patients with atrial fibrillation and the risk of thromboembolism, bleeding, and cardiac death
    Ehrlinder, Hanne
    Orsini, Nicola
    Modig, Karin
    Wallen, Hakan
    Gigante, Bruna
    [J]. RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2022, 6 (07)
  • [6] Antithrombotic therapy and bleeding risk in atrial fibrillation. Fewer unanswered questions
    Ruiz-Nodar, Juan M.
    Marin, Francisco
    [J]. THROMBOSIS AND HAEMOSTASIS, 2013, 109 (03) : 363 - 365
  • [7] Bleeding during antithrombotic therapy in patients with atrial fibrillation
    Chesebro, JH
    Wiebers, DO
    Holland, AE
    Bardsley, WT
    Litin, SC
    Meissner, I
    Zerbe, DM
    Flaker, GC
    Webel, R
    Nolte, B
    Stevenson, P
    Byer, J
    Wright, W
    Anderson, DC
    Asinger, RW
    Newburg, SM
    Bundlie, SR
    Farmer, CC
    Koller, RL
    Haugland, JM
    Nance, MA
    Tarrel, RM
    Dunbar, DN
    Jorgensen, CR
    Sharkey, SW
    Leonard, AD
    Kanter, MC
    Solomon, DH
    Zabalgoitia, M
    McAnulty, JH
    Marchant, C
    Coull, BM
    Kelley, RE
    Chahine, R
    Palermo, M
    Teixeiro, P
    Feldman, G
    Hayward, A
    MacMillan, K
    Gandara, E
    Anderson, W
    Blank, N
    Strauss, R
    Feinberg, WM
    Vold, BK
    Kern, KB
    Appleton, C
    Bruck, D
    Dorr, S
    Dittrich, HC
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1996, 156 (04) : 409 - 416
  • [8] Correlation between risk reduction of major bleeding, thrombosis, and death in non-valvular atrial fibrillation and venous thromboembolism: metaregression of antithrombotic
    Kilo, R.
    Lega, J.
    Provencher, S.
    Bertoletti, L.
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 78 (SUPPL 1) : S40 - S41
  • [9] Oral anticoagulation therapy and subsequent risk of venous thromboembolism in atrial fibrillation patients
    Lutsey, Pamela L.
    Norby, Faye L.
    Zakai, Neil A.
    MacLehose, Richard F.
    Chen, Lin Y.
    Shah, Surbhi
    Datta, Yvonne H.
    Alonso, Alvaro
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2019, 35 (05) : 837 - 845
  • [10] Atrial fibrillation in patients with a history of cancer and risk of bleeding complications associated with antithrombotic therapy
    Chu, G.
    Van Rein, N.
    Huisman, M. V.
    Pedersen, L.
    Klok, F. A.
    Cannegieter, S. C.
    Sorensen, H. T.
    [J]. EUROPEAN HEART JOURNAL, 2021, 42 : 2870 - 2870
12345